Krystal Biotech KRYS
NASDAQ KRYS
$333.01 -2.05 (-0.61%)
As of: Sep 30, 2026 · 3:59 PM EDT

Krystal Biotech (KRYS) Deferred Taxes (2025)

Updated

Krystal Biotech's Deferred Taxes came in at -$1.84 million for Q4 2025.

Analysis

Krystal Biotech (KRYS) Deferred Taxes (2025) Analysis & Trends

For FY2025, Krystal Biotech's Deferred Taxes was $22.85 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn -479.00 Mn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -195.00 Mn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -544.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -398.00 Mn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn -291.00 Mn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -587.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.32 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Krystal Biotech 9.92 Bn 6.69 Bn 112.79 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.84 Mn
API Access

Krystal Biotech Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=KRYS&period=max&api_key=YOUR_API_KEY